QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatmen (Q37277114)
Jump to navigation
Jump to search
scientific article published on May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatmen |
scientific article published on May 2009 |
Statements
1 reference
QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatmen (English)
1 reference
Jessica Kalra
1 reference
Corinna Warburton
1 reference
Karen Fang
1 reference
Lincoln Edwards
1 reference
Tim Daynard
1 reference
Dawn Waterhouse
1 reference
Wieslawa Dragowska
1 reference
Brent W Sutherland
1 reference
Shoukat Dedhar
1 reference
Karen Gelmon
1 reference
Marcel Bally
1 reference
1 May 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference